News & Coverage - PsyIndex

Delic Holdings Inc. Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities

PRNewswire/ - Delic Holdings Inc. (" DELIC " or the " Company ") (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, announces that the Company is not aware of any material undisclosed ...

Business Insider

May 8, 2021

Expert Q&A: MAPS and Psychedelic-Assisted Psychotherapy

An interview with Dr. Michael Mithoefer who has worked on phase 2 trials of MDMA-assisted psychotherapy and trains therapists in these experimental techniques.

psychiatryadvisor.com

May 7, 2021

Psychedelic Drugs Market with Covid 19 Analysis and Challenges On Upcoming Trends 2021-2028

This market report involves the drivers and restraints for Psychedelic Drugs Market that are derived from SWOT analysis and also shows what all the recent developments, product launches, joint ...

The Sentinel

May 7, 2021

How Psychedelics Without Hallucinogenic Effects Could Revolutionize Psychiatry

A new study published in the peer-review journal Cell looks at a novel compound capable of providing some of the therapeutic properties ...

Benzinga.com

May 7, 2021

3 Top Psychedelic Stocks to Own Now

And as a result, psychedelic stocks could be a game-changer for your portfolio. Psilocybin, for example, has been shown to help with depression, anxiety, OCD, PTSD and addiction. LSD may be able to ...

Nasdaq

May 6, 2021

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round

NEW YORK, May 6, 2021 /PRNewswire/ — Gilgamesh Pharmaceuticals, a mental health science focused biotechnology company utilizing psychedelic-related medicines for the treatment of neuropsychiatric c...

CFN Media

May 6, 2021

3 Top Psychedelics Stocks to Own Now

Psychedelics could be a game-changer for millions struggling with mental health issues. Here are some of the top ways to trade its potential.

InvestorPlace

May 6, 2021

REPEAT – Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease

Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has ...

Digital Journal

May 6, 2021

Field Trip Health Ltd. Announces DTC Eligibility

Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“Field Trip”), a leader in the development and delivery of psychedelic therapies, is pleased to announce that its common shares are now ...

Associated Press

May 6, 2021

Video: The Psychedelics Market With Entheon Biomedical, MagicMed, Natan Ponieman

Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday’s show, hosts Patrick Lane and Javier Hasse invited psychedelics journalist Natan Ponieman to discuss the latest news in the ...

Benzinga on MSN.com

May 6, 2021